tripalmitin has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abendschein, DR; Gross, RW; Han, X; Kelley, JG | 1 |
| Counsell, RE; Gross, MD; Longino, MA; Schwendner, SW; Weichert, JP | 1 |
2 other study(ies) available for tripalmitin and Alloxan Diabetes
| Article | Year |
|---|---|
Diabetes-induced changes in specific lipid molecular species in rat myocardium.
Topics: Animals; Arachidonic Acid; Chromatography, Gas; Diabetes Mellitus, Experimental; Male; Mass Spectrometry; Myocardium; Phosphatidylethanolamines; Phosphatidylinositols; Phospholipids; Plasmalogens; Rats; Rats, Sprague-Dawley; Streptozocin; Time Factors; Triglycerides | 2000 |
Potential organ or tumor imaging agents. 32. A triglyceride ester of p-iodophenyl pentadecanoic acid as a potential hepatic imaging agent.
Topics: Animals; Diabetes Mellitus, Experimental; Dogs; Evaluation Studies as Topic; Female; Gamma Cameras; Humans; Iodine Radioisotopes; Iodobenzenes; Lipase; Lipoproteins; Liver; Models, Biological; Neoplasms; Phosphatidylglycerols; Radionuclide Imaging; Rats; Rats, Inbred Strains; Tissue Distribution; Triglycerides; Triolein | 1992 |